FindTrial
Sign In

The clinical outcomes of thoracoscopic versus open lobectomy for non-small-cell lung cancer after neoadjuvant therapy: a multi-center retrospective cohort study

The clinical outcomes of thoracoscopic versus open lobectomy for non-small-cell lung cancer after neoadjuvant therapy: a multi-center retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062690
Enrollment
Unknown
Registered
2022-08-15
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

open group:open lobectomy
minimally invasive group:video-assisted thoracoscopic surgical lobectomy

Sponsors

The First Affiliated Hospital, Zhejiang University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Neoadjuvant lung cancer operation between July 2014 and July 2020; 2. Aged >= 18 years; 3. Preoperative neoadjuvant and postoperative adjuvant therapy information are available.

Exclusion criteria

Exclusion criteria: 1. Patients with a second or multiple primary lung cancer; 2. Patients with distant metastases.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactJian Hu

The First Affiliated Hospital, Zhejiang University, School of Medicine

dr_hujian@zju.edu.cn+86 571 87236847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026